Yu Tokura is a Senior Chemist in the Polymer Compounds Business Group at Mitsubishi Chemical America, specializing in the research and development of medical-grade thermoplastic polyurethane (TPU) materials for a wide range of medical devices. He began his career with Mitsubishi Chemical Corporation in Japan in 2018 and joined Mitsubishi Chemical America in 2021. In his current role, Yu focuses on new product development and technical support, partnering with global customers to address complex application and processing challenges. He combines expertise in polymer science and biochemistry with a practical, solution-oriented approach to collaboration in regulated medical environments. Yu is a co-inventor on two issued patents and holds a PhD from Ulm University in Germany.
As medical device design continues to evolve, engineers are under increasing pressure to deliver softer, more compliant devices without sacrificing long-term performance, durability, or manufacturability. This panel discussion will explore how advances in polycarbonate-based thermoplastic polyurethane (PCTPU) are reshaping material options for patient-contacting and implantable applications by delivering silicone-like softness alongside the mechanical integrity required for demanding long-term use.
Panelists will examine the evolution of medical TPU—from early flexibility-driven materials to today’s platform-based polymer architectures designed for enhanced softness, mechanical strength, and long-term implantability. The discussion will highlight how polymer architecture can be used to achieve silicone-like softness while maintaining critical performance characteristics and thermoplastic processability.